Pindolol (Cadila Healthcare Limited)


Welcome to the PulseAid listing for the Pindolol drug offered from Cadila Healthcare Limited. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cadila Healthcare Limited
NON-PROPRIETARY NAME: Pindolol
SUBSTANCE NAME: PINDOLOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-11-07
END MARKETING DATE: 0000-00-00


Pindolol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPindolol from Cadila Healthcare Limited
LABELER NAME: Cadila Healthcare Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2017-11-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70771-1134_d4078b63-30ad-435b-a081-4d90562962b5
PRODUCT NDC: 70771-1134
APPLICATION NUMBER: ANDA209866

Other PINDOLOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ANI Pharmaceuticals, Inc.Pindolol
Cadila Healthcare LimitedPindolol
Carilion Materials ManagementPindolol
Mylan Pharmaceuticals Inc.Pindolol
Nostrum Laboratories, Inc.Pindolol
Sun Pharmaceutical Industries, Inc.Pindolol
Zydus Pharmaceuticals (USA) Inc.Pindolol